Apple lifts S&P 500 to new record high ahead of Fed decision
May 1, 2019
U.S. economy appearing to slow; labor market strong
May 1, 2019

GSK expects shingles drug sales to exceed $1.3 billion after ‘fantastic’ quarter

GlaxoSmithKline forecast 2019 sales of its fast-growing shingles vaccine Shingrix to be “significantly” more than 1 billion pounds ($1.31 billion) on Wednesday as a drop in the British drugmaker’s free cash flow weighed on its shares.

Powered by WPeMatico